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ABSTRACT
We have used the streptozotocin-induced diabetes mellitus preg-
nant rat as a model of maternal nonthyroidal illness. We measured
the effects of different degrees of diabetes mellitus on maternal body
weight, the outcome of pregnancy, circulating glucose, insulin, T4, T3,
rT3, and TSH in mother and fetus, T4 and T3 in maternal and fetal
tissues, and iodothyronine deiodinases in liver, lung, and brain.
All of the changes in thyroid hormone status typical of nonthyroidal
illnesses were observed in the mothers and were related to the degree
of themetabolic imbalances.Most were controlled with a daily insulin
dose of 0.5 U/100 g BW. Normalization of maternal placental T4,
however, required higher insulin doses than in other maternal
tissues.
The number and body weight of the fetuses, their pituitary GH
contents, and their thyroid hormone status were severely affected.
The total extrathyroidal T4 and T3 pools decreased to one third of
normal fetal values. T4 and T3 concentrations in the fetal brain were
lower than normal, and the expected increase in type II 59deiodinase
activity was not observed. The low cerebral T3 only improved with
adequate insulin treatment of the dams.
It is concluded that maternal diabetes mellitus, and possibly other
nonthyroidal illnesses that impair the availability of intracellular
energy stores, may affect fetal brain T3 when thyroid hormones are
essential for normal development. (Endocrinology 138: 1159–1169,
1997)
DIABETES mellitus leads to alterations of thyroid hor-mone status typical of other so called nonthyroidal
illnesses (1–3). The major alterations in thyroid hormone
economy are a reduction in the TSH stimulation of the thy-
roid gland, probably caused by central hypothyroidism, and
in the peripheral generation of T3 from T4 (3). The injection
of streptozotocin (STZ) in rats is frequently used to obtain an
experimental model for the study of diabetes mellitus, often
as a model of nonthyroidal illness.
In the STZ-diabetic adult rat, the alterations in the hypo-
thalamo-pituitary-thyroid axis are numerous; hypothalamic
and plasma TRH (4, 5), pituitary and plasma TSH, as well as
TSH secretion rate are reduced (4, 6, 7), and the TSH response
to TRH is decreased despite normal peripheral TSH metab-
olism (6). T3 and T4 production (8) and iodide uptake by the
thyroid are diminished. There are also important structural
changes in the thyroid gland and pituitary that are accom-
panied by marked alterations in their secretory activity. In
addition, T4 deiodination to T3 in peripheral tissues is de-
creased (8–10). As a consequence of all of these changes,
circulating levels of T4 and T3 are markedly reduced as are
the concentrations of both iodothyronines in most tissues
(8–10).
These alterations have been shown in the adult diabetic rat,
but to our knowledge very little is known about the possible
influence ofmaternal diabetes on the thyroid hormone status
of the fetus. In a preliminary study (11) we have shown that
STZ-inducedmaternal diabetesmellitus also affects fetal thy-
roid hormone economy, as studied at 20 days gestation,
causing a decrease in T4 and T3 in plasma and most fetal
tissues, including brain. These preliminary results also sug-
gested that the normal response of 59-deiodinase type II
(59D-II) to low T4 concentrations was impaired in the fetal
brain.
The present study has been undertaken to further define
the effects of different degrees of maternal nonthyroidal ill-
ness, as induced by diabetes mellitus, on fetal thyroid hor-
mone status and their prevention with adequate control of
the maternal metabolic imbalances.
Materials and Methods
Experimental design
Female Wistar rats were used for this study. The guidelines for
humane treatment of animals were followed, and the study was ap-
proved by the committee of our institute. They were maintained at 22
Cwith 12-h periods of light and darkness. Theywerematedwith normal
males, and the morning of appearance of the vaginal plug was consid-
ered day 0 of gestation. Thirty pregnant rats were divided into six
groups. One group served as normal pregnant controls (C). At 7 days
gestation (dg), the other five groups of ratswere injected into the femoral
vein with 4.5 mg/100 g BW STZ dissolved in 50 mm citrate buffer, pH
4.5 (12). One of the groups of STZ-treated dams was not injected with
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insulin and served as the long duration diabetes mellitus (D) group, as
14 days had elapsed since injection of the dams with STZ. A second
group of STZ-injected pregnant rats received 1.5 U bovine insulin
(Ultralente, Novo Nordisk, Bagsvaerd, Denmark)/100 g BWzday, sc,
once daily from 9–15 days gestation and vehicle (Diluting Medium for
LenteMC, Novo Nordisk) from 15–20 dg; this group is referred to as sD,
for short duration diabetesmellitus, as the damswere left untreated only
for the last 5 days. Three groups of rats were injected sc once daily with
0.5, 1.0, or 1.5 U bovine insulin/100 g BWzday from 9–20 dg (D10.5 Ins,
D11.0 Ins, and D11.5 Ins groups, respectively). Most results obtained
in D and sD groups were very similar, so only results from D dams will
be presented; differences between D and sD groups, if any, are indicated
in the text, tables, or figure legends.
On themorning of 21 dg and 24 h after the last of the insulin injections,
all dams were anesthetized with ether, bled, and perfused with 40–50
ml 0.05 m phosphosaline buffer, pH 7.4, as previously described (13).
Maternal plasma, liver, brain, lung, heart, and samples of mammary
tissue were obtained and frozen. The uterus was dissected out and
carefully rinsed and blotted free of maternal blood. The fetuses were
then dissected out, bled, separated from the placenta, weighed, and
immediately placed on ice. The fetal brain, liver, and lungwere dissected
out and quickly frozen on dry ice; the thyroid, adhering to the trachea,
was withdrawn and frozen. Two or three fetal thyroids and pancreas
from each litter were fixed in toto by immersion in PBS containing 4%
formaldehyde for morphological study. The rest of the fetus, referred to
here as the carcass (whole embryo minus the blood, trachea, thyroid,
liver, lung, brain, and heart) was stored frozen. The placentas were
separated, weighed, and divided into the basal (maternal) and labyrinth
(fetal) sides with blunt forceps and frozen rapidly, as previously
described (14).
Determination of thyroid hormone concentrations
Thyroid hormone levels were determined by RIAs after extraction
and purification of plasma and tissues (15). In brief, methanol is added
to the still frozen tissue sample and homogenized, with tracer amounts
of [131I]T4 and [
125I]T3 added to each homogenate. This is followed by
the addition of chloroform in a volume double that of methanol, cen-
trifugation, and a further extraction of the pellet with chloroform-meth-
anol (2:1). This extracts more than 90% of the endogenous and added
iodothyronines. The iodothyronines are then back-extracted into an
aqueous phase and purified by passing this aqueous phase through
Bio-Rad AG 1 3 2 resin columns (Bio-Rad, Hercules, CA). After a pH
gradient, the iodothyronines are eluted with 70% acetic acid, which is
then evaporated to dryness and dissolved in RIA buffer. Each extract is
extensively counted to determine the recovery of the [131I]T4 and [
125I]T3
added to each sample during the initial homogenization process. The
samples are submitted to highly sensitive RIAs for the determination of
T4 and T3; the limits of sensitivity are 2.5 pg T4 and 1.5 pg T3/tube. The
cross-reactivities of the different iodothyronines and metabolites were
as reported previously (15, 16). Each sample is processed in duplicate or
triplicate at two or more dilutions. Concentrations were then calculated
using the amounts of T4 and T3 found in the respective RIAs, the indi-
vidual recovery of the [131I]T4 and [
125I]T3 added to each sample during
the initial homogenization process, and the weight of the tissue sample
submitted to extraction.
Maternal samples were processed individually. Plasma from differ-
ent fetuses were pooled to obtain 300- to 400-ml aliquots. Fetal tissues
were pooled (two or three organs per pool) for the determination of T4
and T3. Pools were obtained from fetuses of the same litter.
The fetal thyroids were pooled in groups of two or three, homoge-
nized, and submitted to proteolytic digestion, followed by methanol
extraction. The methanol extracts were submitted to evaporation to
dryness in a microwave oven at maximum heat for 5–10 min; this
prevents artifacts in the RIAs, presumably due to residual proteolytic
activity transferred into the RIA tube. RIA buffer was added, and T4 and
T3 were determined by RIA, as described above.
Percentage of circulating free T4 and T3
These percentages were determined by ultrafiltration of undiluted
plasma samples, as described by Mendel et al. (17) with modifications.
High specific activity [125I]T4 or [
125I]T3 (;300,000 cpm) were added in
a 5-ml volume to 300 ml plasma and incubated at room temperature for
1 h. A 280-ml aliquot of each was submitted to ultrafiltration using
Microcon 10 microconcentrators (Amicon Division, W. R. Grace Co.,
Beverly, MA) and a 20-min centrifugation at 14,000 rpm. A measured
volume of each ultrafiltrate was added to 0.5 ml bovine serum, sub-
mitted to precipitation with 10% trichloroacetic acid (TCA), and cen-
trifuged; the pelletwaswashed twicewith the same solution of TCA. The
washed pellet was counted, and its radioactivity was calculated as a
percentage of the initial added tracer, submitted to the same TCA pre-
cipitation and washing procedure. This percentage of free T4 (% FT4) or
free T3 (% FT3) and the T4 and T3 concentrations determined byRIAwere
used to calculate the concentrations of FT4 and free FT3, respectively.
Iodothyronine 59- and 5-D activities
Before each assay, [125I]rT3 or [
125I]T4 was purified by paper electro-
phoresis to separate the iodide. Iodothyronine 59D-I activitywas assayed
as previously described (16), using 2 mm dithiothreitol (DTT) and 400
or 200 nm rT3 for maternal and fetal liver, respectively, and 2 nm rT3 and
20 mm DTT for maternal and fetal lung (59D-I). Maternal and fetal brain
59 D-II activities were assayed (18) using 2 nm T4, 1 mm T3, and 20 mm
DTT in the presence of 1 mm 2-N-propyl-6-thiouracil (PTU). The 125I2
released was separated by ion exchange chromatography on Dowex-
50W-X2 columns equilibrated in 10% acetic acid. The production of
equal amounts of iodide and 39,3-diiodothyronine (39,3-T2) was checked
in some assays. The protein content was determined by the method of
Lowry, after precipitation of the homogenates with 10% TCA to avoid
interference from DTT in the colorimetric reaction (16).
5D activity was measured in maternal and fetal brain homogenates
(19), incubating 20–50mg protein in 100mm potassiumphosphate buffer
(pH 7.4), 1 mm EDTAwith approximately 50,000 cpm inner ring labeled
5-[125I]T3, 50 nm T3, 20 mm DTT, and 1 mm PTU for 60 min at 37 C.
Radioiodide release wasmeasured as described above.When necessary,
inner ring labeled ([5-125I]T3 was repurified before use with disposable
Sep-Pak C18 cartridges (Waters Associates, Milford, MA) and methanol.
Other determinations
rT3 concentrations in maternal and fetal plasma and in placental
extracts were determined by RIA, as previously described (14).
Maternal and fetal plasma glucose levels were determined by the
glucose oxidase method (20), using 10–25 ml plasma.
Insulin levels in maternal and fetal plasma were measured using the
specific RIA adapted for rat insulin with reagents supplied by Novo
Nordisk (Bagsvaerd, Denmark). We used rat insulin as standard, anti-
porcine antiserum, and human 125I-labeled insulin as antigen (18). A
bovine insulin standard was used for the standard curve when the
plasma was obtained from mothers injected with bovine insulin.
TSH was determined in 200-ml aliquots of maternal plasma, and GH
was determined in fetal pituitaries, using the immunoreactants for RIA
kindly supplied by theNIH (Bethesda,MD) andmade available through
the Rat Pituitary Agency of the NIDDK. Concentrations are expressed
in weight equivalents of the rat TSH RP-3 and rat GH RP-2 reference
preparations (21).
Drugs and reagents
T4, T3, 3,5-T2, PTU, and DTTwere obtained from Sigma Chemical Co.
(St. Louis, MO). rT3 and 39,3-T2 were obtained from Henning Berlin
(Berlin, Germany). High specific activity [131I]T4, [
125I]T3, [
125I]T4, and
[125I]rT3 (3000mCi/mg)were synthesized in our laboratory (15) and used
for highly sensitive T4, T3, and rT3 RIAs, as recovery tracers for extrac-
tions, and as substrates for 59-D.
Inner ring labeled 5-[125I]T3 (80 mCi/mg) was used as substrate for
5-D. It was provided by Drs. R. Thoma and H. Rokos from Henning
Berlin.
Statistical analysis
After testing for homogeneity of variance using Bartlett’s procedure
for groups of unequal size, data were submitted to one-way ANOVA.
Square root or logarithmic transformations usually ensured homoge-
neity of variance when this was not achieved with the raw data. Sig-
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nificant differences among groups were assessed using the protected
least significant difference test. All statistical calculations were per-
formed as described by Snedecor and Cochran (22). The se appearing in
the tables and figures is the mean se calculated by ANOVA and used
for the identification of statistically significant differences between
groups by the least significant difference test. For the sake of clarity, the
6se is shown in figures only on the C value bar.
Possible interrelations among variables were tested by curve fitting
of the individual data using Cricket Graph III for Macintosh (Computer
Associates International, Inc., Islandia, NY), and the degree of fit was
assessed from the corresponding value of r and the degrees of freedom.
Results
Experimental design
The aim of the present experimental design was to induce
maternal diabetes mellitus of different duration and degree
and to assess the effects of these different degrees ofmaternal
nonthyroidal illness on fetal thyroid hormone status near
term.
Degree of nonthyroidal illness: diabetic state and weight loss of the
dams. Figure 1 shows the insulin and glucose concentrations
in thematernal plasma (M-plasma) from the different groups
at 21 dg. Insulin decreased significantly in all D dams. As
expected, circulating glucose levels were very high in all
STZ-injected dams that did not receive insulin. The injection
of insulin affected both insulin and glucose levels in the
maternal circulation. Normal levels of insulin, as measured
24 h after the last injection, were found in the D10.5 Ins or
D11.0 Ins groups, with higher than normal values in the
D11.5 Ins dams. Circulating glucose was somewhat higher
than C values in the D10.5 Ins dams, although markedly
decreased compared to those in D animals, and comparable
to those in C dams in the D11.0 Ins and D11.5 Ins groups.
The circulating glucose was inversely related to plasma in-
sulin by a power function (n 5 30; r 5 0.88; P , 0.001).
Figure 1 also shows the calculated change, between 7 and
21 dg, in the body weight of the pregnant rats, free of the
conceptus (M-BW), namely the total measured weight of the
damminus theweight of the conceptus. The change inM-BW
was calculated from data reported in Table 1, such as the
change in total weight, the number of fetuses per litter, the
body weights of the fetuses (F-BW), and the weights of the
placentas. The weight of the conceptus was calculated for
each animal from the sum of the weights of all fetuses and
placentas in each dam. Although extraembryonic fluids and
membranes had not been collected, the sum of the fetal and
placental weights appears to be a reasonable approximation
of the totalweight of the conceptus. The change inM-BWwas
calculated by subtracting this calculated weight of the con-
ceptus from the measured change in total weight of the
animal. As shown in Fig. 1, the mean net increase in M-BW
of C dams was 27.8 6 4.3 g. In contrast, in all D dams, there
was a net loss of M-BW, which was prevented by insulin
treatment.
Both the increment in total weight and the change in
M-BW were significantly related to decreasing glucose and
increasing insulin concentrations in the maternal circulation
and appear to be good indexes of the degree of maternal
illness. The closest fit was found for the change in M-BW vs.
the logarithm of the M-plasma insulin levels (Fig. 2).
Effects of maternal illness on the outcome of pregnancy. No re-
productive abnormalities were observed in the normal (C)
dams (Table 1). There were originally eight dams in the D
group, four dams in the sD group, and four each in the three
D1insulin groups.Whenever only reabsorbed fetuses or less
than two apparently viable fetuses were found in the uterine
cavity of these dams, they were excluded from the study.
This reduced the number of dams in the D group. The pro-
portion of dams inwhich such abnormalitieswere foundwas
more frequent in the D groups. Treatment with insulin only
appeared to effectively prevent these abnormalities in the
D10.5 Ins dams, which in these reproductive aspects were
comparable to C animals.
The weight of the conceptus (not shown) was lower than
normal in D groups. This was due to a smaller number of
apparently viable fetuses, a decreased F-BW, or both. Treat-
ment with insulin had variable effects; F-BW improved with
respect to theDdams in theD10.5 Ins andD11.5 Ins groups,
especially in the former, althoughC valueswere not reached,
whereas both number and F-BW in theD11.0 Ins groupwere
as poor as in D dams.
The various treatments did not similarly affect the fetal
and maternal sides of the placenta. Although mean F-pla-
cental weights tended to change in parallel with the total
placental weight, the weight of the M-placenta decreased in
D groups compared to that in C dams. In the insulin-treated
animals, the weight of the M-placenta only increased to nor-
mal values in the D10.5 Ins group and was actually smaller
than normal in the D1 1.5 Ins group.
In summary, the outcome of pregnancy was affected by
FIG. 1. The mean (6SE) circulating insulin and glucose concentra-
tions in the plasma of dams from the different groups are shown. The
right panel shows the difference between the change in total weight
and theweight that can be attributed to the conceptus. This difference
represents the change in the body weight of the mother herself (M-
BW) between 7 and 21 dg. In this and the following figures, the SE
shown only on the C value bar is the mean SE calculated by ANOVA.
The shaded area corresponds to themeanC value6 SE. *, Statistically
significant differences vs. C dams; #, statistically significant differ-
ences vs. the D group. Other statistically significant differences are
not identified for the sake of clarity. The circulating insulin levels of
sD dams (not shown) were very low, but somewhat higher than those
of D dams, and the net loss inM-BW in sD dams was also less marked
than that in D dams. For insulin or glucose values there was no
statistically significant difference between the D10.5 Ins and D11.0
Ins dams, whereas insulin and glucose were different in the plasma
of D11.0 Ins vs. D11.5 Ins animals. There were no statistically
significant differences in the change in total body weight, weight of
the conceptus, or maternal body weight among the three insulin-
injected groups, with the exception of the weight of the conceptus in
the D10.5 Ins dams, which was greater than those in the D11.0 Ins
and D11.5 Ins dams.
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the maternal diabetic state and illness. The negative effects
were best prevented with the administration of 0.5 U
insulin/100 g BWzday.
Effects on thyroid hormone status of the mothers
The circulating concentrations of T4, T3, rT3, and TSH as
well as the % FT4, % FT4, % FT3, and % FT3 are shown in Fig.
3. Figure 4 shows the concentrations of T4 and T3 in the liver,
lung, brain, heart, andmammary tissue. Iodothyronine deio-
dinase activities in somematernal tissues are shown in Fig. 5.
Effects of the diabetic state.Mean values of T4, T3, and rT3 in the
maternal circulation and of T4 and T3 in most tissues studied
were lower inDdams than in Cmothers, with the differences
between C and D dams being statistically significant with
few exceptions (brain T4 and mammary gland T3
concentrations).
Circulating % FT4 was increased in the diabetic dams to
twice the values normal for the pregnant dam. This increase
was comparable to the decrease in total circulating T4, as a
result of which the mean circulating FT4, although lower in
D compared to C dams, was not statistically different from
that in the C mothers. The % FT3 also increased in D com-
pared to C dams, but not to the extent that it could com-
pensate for the decrease in circulating total T3, and the FT3
concentration was lower than that in C dams.
59D-I activity in the liver and lung were decreased in the
diabetic dams (Fig. 5), a finding consistentwith the decreased
hepatic andpulmonary thyroid hormone concentrations. De-
spite the decreased plasma T4 concentrations, no significant
change was observed in the 59D-II activity of the cortex, a
finding consistent with the lack of decrease in the cerebral T4
concentration. The 5D-III activity of the cortex was not dif-
ferent in D and C dams.
Effects of insulin treatment of the D dams on their thyroid hormone
status. The injection of insulin either normalized circulating
T4, T3, and rT3 concentrations or resulted in supraphysiologi-
TABLE 1. Mean (6SEM) values of the increments in total body weight (BW) between 7–21 days gestation, number of fetuses per dam,
body weights of fetuses (F-BW), and weights of the placenta (total, maternal, and fetal sides) at 21 days gestation, of normal (C) and
streptozotocin-injected dams (sD and D), and of D dams treated with different daily doses of insulin
Group No. ofdamsa
Increment in total
wt (g)
No. of fetuses/
dam F-BW (mg) Placental wt (mg)
M-placental
wt (mg)
F-placental
wt (mg)
C 7 (7;0) 100.0 6 2.5 12.4 6 1.0 4872 6 32 510.6 6 7.9 154 6 9 339 6 11
D 7 (8;5) 31.6 6 8.8b 10.0 6 1.3 3196 6 66b 568.1 6 12.2b 116 6 4b 361 6 11
D 1 0.5 Ins 4 (4;0) 71.3 6 10.6b,c 10.8 6 1.8 4097 6 65b,c 531.2 6 14.6c 136 6 5 326 6 11
D 1 1.0 Ins 4 (4;2) 58.3 6 7.6b,c 7.5 6 1.0b,d 3141 6 85b,d 482.6 6 10.5c,d 126 6 6b 317 6 9
D 1 1.5 Ins 4 (4;3) 65.3 6 8.4b,c 8.8 6 1.1e 3465 6 150b,c,e,f 472.4 6 10.4b,c,e 107 6 8b,e,f 299 6 15b,c
a The figures given are those of the number of dams included in the final evaluation of the results of the present study. When only reabsorbed
embryos (or fewer than two apparently viable fetuses) were found in the uterine cavity, the dams were excluded from the study; their number
minus that initially allotted to each treatment group is shown. This initial figure is given inside parentheses followed, in italics, by the number
of dams in which reabsorbed fetuses were found.
b Statistically significant differences (P , 0.05) vs. C group. Although not shown, the F-BW of sD animals was significantly different.
c Statistically significant differences (P , 0.05) vs. D group. Although not shown, the F-BW of sD animals was significantly different.
d Statistically significant differences (P , 0.05) between D 1 0.5 Ins and D 1 1.0 Ins.
e Statistically significant differences (P , 0.05) between D 1 0.5 Ins and D 1 1.5 Ins.
f Statistically significant differences (P , 0.05) between D 1 1.0 Ins and D 1 1.5 Ins.
FIG. 2. The mean change in total weight (DW(T)) or in maternal body
weight (DM-BW) are plotted against the mean maternal plasma in-
sulin concentrations (left panel) or themeanmaternal plasma glucose
levels (right panel) on logarithmic scales. The r values shown corre-
spond to the curve fit obtained using all individual paired values (n 5
30 for each correlation) and were all statistically significant (P ,
0.001). The closest fit of the data was found for the positive lineal
correlation between the calculated change in maternal body weight
and the logarithm of circulating insulin.
FIG. 3. The mean concentrations of T4, % T4, FT4, T3, % T3, FT3, rT3,
and TSH in thematernal circulation are shown for the various groups
of dams. See Fig. 1 for the meaning of the shaded area and the
symbols. Data for sD dams (not shown) were comparable to those for
D dams, except for circulating TSH, which was still comparable to
those for C dams. There were no statistically significant differences
in the rT3 and TSH concentrations among the three groups of insulin-
injected dams. The T4 and T3 levels were the same for the D10.5 Ins
and D11.0 dams, but were higher in the D11.5 animals.
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cal levels (Fig. 3). Thus, the maternal hypothyroxinemia
caused by the diabetic state was avoided in all of the insulin-
treated D dams. TSH concentrations improved with the in-
jection of insulin, except in the D11.0 Ins dams.
The effects of treatmentwith insulin depended on the dose
used. In the D10.5 Ins dams, all parameters of thyroid func-
tion that were affected by the diabetic condition were main-
tained within the normal range, with the exception of heart
T4 concentrations, which remained lower than normal. The
effects in the two groups on the higher doses of insulin were
more variable; higher than normal concentrations of the io-
dothyronines were often found in plasma and tissues. This
occurred at different insulin doses, depending on the tissue
and whether T4 or T3 concentrations were being considered.
The injection of insulin reversed to normal the decreased
liver and lung 59D-I activities or increased this activity to
supraphysiological levels in the lung of the D11.0 dams. On
the contrary, the mean 59D-II activity in the maternal cortex
decreased with increasing insulin doses; the difference with
respect to both D and C dams was significant in the D11.5
Ins group. The 5D-III activity of the cortex increased in the
D10.5 Ins group above the values found in C and D dams,
then decreased in an apparently insulin dose-dependent
fashion.
Relationships between the degree of maternal illness and several
indexes of maternal thyroid hormone status. To exclude differ-
ences related to the duration of the diabetic state, data from
sD dams were not used for this evaluation. The changes in
all circulating parameters of thyroid status (T4, % FT4, T3, %
FT3, rT3, and TSH) were closely correlated to the degree of
maternal diabetes and illness, whether measured by the cir-
culating glucose or insulin levels or the change in M-BW.
When the parameters of thyroid hormone statuswere plotted
against the above indexes of maternal metabolic imbalances,
data fit linear functions, with values of r ranging from 0.77–
0.85 (P , 0.001 in all cases).
The changes occurring in the activities of liver and lung
59D-I were also closely related to the circulating glucose and
insulin levels and the change in M-BW, with r values for the
fit to linear functions ranging from 0.75–0.84 (P , 0.001). In
contrast, no such relationships were found between the ce-
rebral cortex 59D-II and 5D-III activities and these indexes of
the diabetic state.
Relationships between several indexes of maternal thyroid hormone
status. Circulating TSH changed in parallel to plasma T3 and
not inversely, as expected if the negative feedback between
the pituitary and thyroid was operative.
Although the patterns of changes in T4 and T3 concentra-
tions in tissues appeared similar to those described for their
respective circulating levels, we observed that the changes
occurring in the different tissues could not be predicted from
those in the corresponding plasma levels (total or free). Thus,
for instance, the concentrations of T3 in brain, heart, and
mammary tissue of the D dams were at least 2-fold higher
than expected from plasma T3 or FT3 levels.
Liver 59D-I activity was fitted to a linear function of liver
T3 concentration, with an r 5 0.826 (P , 0.001). The lung
59D-I, cortex 59D-II, and cortex 5D-III levels were more
poorly fitted to linear functions when plotted against their
tissue or plasma concentration of T4 and T3, with r values 0.60
or less.
Effects on the fetal compartment
Thyroid hormone status of the placenta. Figure 6 shows the
concentrations of T4, T3, and rT3 in the M- and F-placenta,
which decreased in the D dams and returned to normal or
FIG. 4. The mean (6SE) concentrations
(nanograms per g wet wt) of T4 and T3
are shown for liver, lung, brain, heart,
andmammary tissue. The shaded areas
and symbols are explained in Fig. 1.
There were no statistically significant
differences in the T4 concentrations
found in liver, lung, and brain of dams
receiving the various insulin doses. The
concentration of T3 in these tissues was
lower in theD10.5 Ins dams than in the
D11.0 Ins and/or D11.5 Ins mothers.
FIG. 5. Themean (6SE) activities of the outer ring 59D, type I for liver
(picomoles of I2 per min/mg protein) and lung (femtomoles of I2 per
h/mg protein), type II for cortex (Cx; femtomoles of I2 per h/mg pro-
tein), and Cx inner ring 5D-III (picomoles of I2 per h/mg protein) are
shown. The shaded areas and symbols are explained in Fig. 1. Al-
though decreased in sD dams (not shown) compared to those in C
dams, liver and lung 59D-I activities were somewhat higher than
those in D animals. There were no insulin dose-related differences in
liver or brain 59D activities. The activity in lung in D11.0 Ins dams
was higher than those in D10.5 and D11.5 Ins rats.
MATERNAL AND FETAL THYROID STATUS IN DIABETES MELLITUS 1163
 by on May 7, 2010 endo.endojournals.orgDownloaded from 
higher than normal values in D1Ins dams. There were quan-
titative differences between the M- and F-placenta with re-
gard to the effects of diabetes and the various doses of
insulin.
In the F-placenta, the changes in T4 and rT3 concentrations
are comparable to those described in maternal circulating
levels. On the contrary, in the M-placenta, T4 and rT3 con-
centrations were lower than expected from the circulating
levels; the concentrations in the M-placenta of D dams de-
creased more in C dams than the observed change in the
respective circulating levels and increased to only half the
expected levels with insulin treatment. M-placenta T4 was
only normal in the D11.5 Ins group, in which the circulating
concentrations were clearly above C values. In contrast, T3
concentrations in theM-placenta of D dams, whether treated
with insulin or not, were higher than expected from T3 cir-
culating levels.
Thyroid hormone status of the fetus. Figure 7 shows the plasma
glucose and insulin concentrations as well as the GH content
of the F-pituitary. F-plasma glucose was markedly elevated
in the progenies fromDdams. Treatment of themotherswith
insulin resulted in a dose-dependent decrease in F-plasma
glucose; the fetuses from the D11.5 Ins dams actually were
hypoglycemic compared to those fromnormal dams, asmea-
sured 24 h after the injection of insulin into theirmothers. The
insulin levels in the fetal circulation were low in the fetuses
from D dams, returning to normal in the D10.5 Ins group,
then decreasing in an insulin dose-dependent fashion. The
pituitary GH content was lower in fetuses fromDdams, with
an ameliorating effect observed in fetuses from insulin-in-
fused D dams (except in the D11.0 Ins group), although
pituitary GH content was far from normal values.
Total thyroidal T4 and T3 contents (Fig. 8) decreased in the
fetuses from the diabetic mothers, with little improvement
noted in the insulin-treated groups, except for a normaliza-
tion of the T3 content in the D10.5 Ins and D11.5 Ins fetuses.
The T4 and T3 concentrations
1 in the fetal circulation (Fig. 8)
decreased in the D groups and improved in the fetuses from
insulin-treated dams, although not in an insulin dose-de-
pendent fashion. The % FT4 (not shown) increased from
0.1266 0.002% in C fetuses to 0.1746 0.016% in fetuses from
D dams (P , 0.01). Unfortunately, there was not enough
plasma to measure changes in % T3 or changes in % T4 in the
other groups.
The T4 and T3 concentrations in different F-tissues (Fig. 9)
decreased in tissues from D groups. Treatment of the moth-
ers with insulin usually resulted in improved T4 and T3
concentrations in most F-tissues compared to those in D
fetuses. However, in most tissues an insulin dose-dependent
effect was not observed, and improvement was minimal in
the D11.0 Ins group.
T4 and T3 in the carcass (not shown) of fetuses from D
mothers were lower (0.69 6 0.06 ng T4/g and 0.16 6 0.01 ng
T3/g) than those in fetuses from C dams (1.716 0.09 ng T4/g
and 0.33 6 0.03 ng T3/g; P , 0.001 for both T4 and T3). The
total fetal extrathyroidal T4 and T3 poolswere calculated (24);
the T4 pool decreased from 13.08 ng in C to 4.05 ng in D
fetuses, and the T3 pool decreased from 1.72 ng in C to 0.63
1 Circulating TSH levels are not shown: due to the small amounts of
plasma available for the different determinations, the plasma aliquots
were one fourth the usual ones for the determination of TSH, and the
levels in F-plasma from all groups were below reliable detection.
FIG. 7. The mean concentrations of glucose and insulin in the fetal
circulation are shown as well as GH content of the fetal pituitary. The
shaded areas and symbols are explained in Fig. 1. The glucose and
insulin levels of the D11.5 Ins fetuses were significantly lower than
those of the D10.5 Ins and D11.0 Ins fetuses. The pituitary GH
content was lower in the D11.0 Ins fetuses than in those from dams
injected with the lower and higher doses of insulin.
FIG. 8. Total T4 and T3 contents are shown for the fetal thyroids of
the different experimental groups, as determined in proteolytic di-
gests of the glands. Their corresponding concentrations in the fetal
circulation are also shown. The shaded areas and symbols are ex-
plained in Fig. 1.
FIG. 6. The concentrations of T4, T3, and rT3 in thematernal and fetal
placenta are shown for the various groups of dams in nanograms per
g. The shaded areas and symbols are explained in Fig. 1. The con-
centrations of T4 and T3 were significantly different in the dams
receiving the three different insulin doses; rT3 was higher or lower,
respectively, in theM-placenta and F-placenta of the D11.0 Ins dams
than in the D10.5 or D11.5 Ins animals.
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ng in D animals. The extrathyroidal pools of T4 and T3 in D
fetuses were markedly reduced, to 31% and 36%, respec-
tively, of the normal values.
In D fetuses, 59D-activity was lower than normal in F-liver
and F-lung (Fig. 9) and were restored to normal values in
fetuses from insulin-treated dams, with the exception of F-
liver in the D11.0 Ins group, where it was actually reduced
below D levels. 59D-II activity in the F-brain was unchanged,
except for a decrease in D11.0 Ins fetuses. Fetal brain 5D-III
activity (not shown) of normal fetuses was 6.09 pmol/hzmg
protein and did not decrease significantly in fetuses from D
dams, but increased slightly with insulin treatment of the
mothers to 6.83 pmol/hzmg protein (similar results were
observed regardless of the insulin dose).
Relationships between fetal and maternal thyroid hormone
levels and between parameters of fetal thyroid hormone
status
There was a very good correlation between the glucose
concentrations in the fetal and maternal circulations (n 5 33;
r5 0.96; P, 0.001), but not between insulin levels. The latter
was due to the finding that in the insulin-treated groups,
insulin levels in M-plasma increased proportionally to the
administered dose, whereas they decreased in F-plasma.
The F-BW (Table 1) was affected by the maternal diabetic
state. This decrease was not totally corrected with any of the
doses of insulin administered to the dams, but the closest to
normal F-BW were observed for fetuses from the D10.5 Ins
mothers, and the lowest was found in fetuses fromD11.0 Ins
dams. The F-BWwas related to other indexes of the outcome
of pregnancy, such as the number of viable fetuses per litter
(n 5 29; r 5 0.63; P , 0.001). F-BW was clearly related to the
GH content of the fetal pituitary (Fig. 8), with a good fit to
a linear function of F-BW vs. the logarithm of the GH content
(n 5 33; r 5 0.87, P , 0.001). With the exception of the
F-plasma T3 level, the T4 and T3 concentrations in F-tissues
were more closely correlated to the F-BW and pituitary GH
content than to the changes in maternal thyroid hormone
status.
The total T4 and T3 contents in the thyroid gland of fetuses
from the different treatment groups did not correlate with
their changes in F-plasma or F-tissues. The changes observed
in the concentrations of T4 andT3 in the F-tissueswere similar
to those in the corresponding hormone in F-plasma, as the
F-tissue to F-plasma ratios (not shown) were usually the
same as those in fetuses fromC dams, except for T3 in F-liver,
F-lung, and F-brain in the D11.0 Ins group, whichwas lower
than expected from the F-plasma levels.
Changes in the thyroid hormone status of the fetuses from
D groups were similar to those in their mothers. On the
contrary, the effects of insulin treatment on T4 and T3 con-
centrations were different. Treatment of the D dams with
insulin usually resulted in insulin dose-dependent changes,
whereas there was no clear relationship between the insulin
dose and fetal T4 and T3 concentrations. There was also no
correlation between the changes in thyroid status of the fe-
tuses and F-plasma insulin. As indicated above, there was a
better correlation with F-BW and pituitary GH content.
The activities of 59D-I in F-liver and F-lung and of 59D-II
and 5D-III in F-brain, either did not correlate with the T4 and
T3 in F-plasma or in F-liver and F-lung, or did so poorly, with
r values of 0.5 or less. No clearly significant correlations were
found between these enzyme activities and the F-plasma
glucose levels. Changes in the activities of 59D-I in F-liver and
F-lung and 59D-II in F-brain were less marked than those in
the corresponding maternal tissues.
Discussion
Present results confirm and extend our preliminary ob-
servations on the effects of maternal STZ-induced diabetes
mellitus on fetal thyroid hormone status, as studied on 20 dg
(11), which are likely to result from the altered carbohydrate
metabolism of their mothers, and not from a direct destruc-
tive action of STZ on the fetal pancreas. The half-life of
disappearance of STZ from the circulation is 5 h in rodents
(23). The drug, injected at 7 dg, would no longer be present
by the time the b-cells of the fetal pancreas develop in the rat
(12.5–13.5 dg), long before themorphological structure of the
b-cells is achieved on 18 dg (24). Moreover, when maternal
hyperglycemia was mitigated with insulin, F-plasma insulin
was normal, indicating that fetal b-cells were functional. As
the placenta is impermeable to maternal insulin (25), this
would not occur if the fetal pancreas had been directly af-
fected by the drug. The pancreas of the hyperglycemic fe-
tuses of the present D dams showed hyperplasia, hypertro-
FIG. 9. The three upper panels show the concentrations (in nano-
grams per g) of T4 in the liver, lung, and brain of the fetuses from the
various groups of dams, with the middle panels showing the corre-
sponding T3 concentrations. The three lower panels show the activity
of the outer ring 59D, type I for liver (picomoles of I2 per min/mg
protein) and lung (femtomoles of I2 per h/mg protein) and type II for
cortex (Cx; femtomoles of I2 per h/mg protein). The shaded areas and
symbols are explained in Fig. 1.
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phy, and degranulation of immunochemically identified
insulin-positive b-cells (our unpublished data), confirming
the findings of others (26) and indicating b-cell overstimu-
lation and exhaustion.
A direct toxic effect of STZ on the placenta is also unlikely.
Ultrastructural changes in the placenta have been described,
but were less frequent when insulin was supplied (27),
whereas a direct toxic effect would be independent from
treatment with insulin. In a previous study (unpublished) in
which the rats were treated with STZ before conception and
maintained with insulin until midgestation, we found the
same changes in the concentrations of both T4 and T3 in the
M-placenta as those described here for dams treated with
STZ during pregnancy; T4 decreased to 16% of C values, and
T3 to 63%. The F-BW of the dams given STZ pregestationally
was similarly affected as that of the present D fetuses, de-
creasing to 67% of C values.
The pregnant rat with diabetes mellitus as a model of
maternal nonthyroidal illness
The changes in thyroid hormone status occurring in non-
thyroidal illness are at present considered adaptive re-
sponses to a limited availability of intracellular energy, a
situation in which a decrease in T3-dependent catabolic ef-
fects would be beneficial (1, 2). Several mechanisms are in-
volved in these responses, of which two are best known,
namely 1) a decreased thyroidal secretion of both T4 and T3,
whichwould lower the pool of T4 available for extrathyroidal
generation of T3, and 2) a decrease in the activity of enzymes
involved in the extrathyroidal generation of T3 from T4.
1) The sequence of events involves decreased release of
hypothalamic TRH (4, 5), secretion of TSH (4, 6, 7), and
sensitivity of the thyroid to TSH (6), which supersede the
normal feedback mechanism; TSH decreases despite the
lower levels of circulating total and/or free T4 andT3. Indeed,
a return to a normal secretion of TSH and thyroidal release
of hormones is considered an indication that the illness is
remitting or that the metabolic alterations are under control.
The present changes in circulating total and free T4 and T3
together with decreased TSH and the low T4 and T3 levels
found in all of the tissues studied are in agreement with the
changes described in the nonpregnant diabetic rats (8) and in
patients dying from nonthyroidal illnesses (28).
2) Direct measurement of 59D-I activities in the liver and
lung has confirmed that generation of T3 fromT4 is decreased
in diabetic rats (11, 29, 30) and is consistent with a decreased
expression of 59D-Imessenger RNA (29). 59D-II activity in the
cerebral cortex of D damswas not changed, possibly because
cerebral T4 was not decreased, and confirming the lack of
change described in nonpregnant diabetic rats (10, 31).
Treatment with insulin: varying severity of maternal illness
The diabetic state of the dams improved. The best results
were observed in the D10.5 Ins group both with respect to
parameters of diabetes mellitus and reproductive compe-
tence and with respect to thyroid hormone status, including
circulating TSH and liver and lung 59D-I activities.
The two higher doses of insulin used in the present study
might well have been excessive; the glucose and insulin
levels were normal 24 h after the last injection, suggesting
daily periods of hypoglycemia. Most, but not all, changes in
parameters of maternal thyroid hormone economy appeared
to be insulin dose dependent.
Effects on the placenta
In diabetic women and rats, hyperglycemia increases pla-
cental weight and placental glycogen content (32). The pla-
centas from the present D dams were clearly affected. It is
very difficult to properly regulate placental function and
fetal metabolism in diabetic mothers with insulin (33) ad-
ministered once daily,2 possibly because of the daily cycles
of hyper- and hypoglycemia, or constant hypoglycemia.
These were more likely to occur in the D11.0 Ins and D11.5
Ins dams. Indeed, the best resultswere observed in theD10.5
Ins dams, which were not likely to have undergone pro-
longed periods of hypoglycemia.
The placenta plays a very important role in the supply of
nutrients and indetermining themetabolic status of the fetus.
Posner et al. (34) suggested that insulin might promote sub-
strate transport across the placenta, which has insulin re-
ceptors. The rat placenta is permeable to maternal T4 and T3
(13, 14) and is active in the local metabolism of both iodo-
thyronines, as it contains iodothyronine deiodinase isoen-
zymes, with 59D-II activity highest in the M-placenta (35),
and 5-III highest in the F-placenta (36).
Although T4 and T3 decreased in the placenta of D dams
and reversed to normal or supraphysiological levels with
insulin treatment, the changes occurring in the M-placenta
were quantitatively different from those found in M-plasma.
T4 concentrations decreased more than expected from the
changes in circulating total T4 or FT4, in agreement with our
previous report (11). The opposite was observed for the con-
centrations of T3 in the M-placenta, which increased more
with insulin treatment than expected from the circulating
changes in total T3 and FT3. The differences in thyroid hor-
mone status of the M-placenta compared to other M-tissues
may well be related to the decreased uteroplacental blood
flow caused by a significant reduction in the arterial blood
velocity in the uterine artery, placenta, umbilical artery, and
fetal aorta (37). The mechanisms, if any, regulating placental
permeability to the iodothyronines and their metabolism in
the M- and F-placenta are unknown at present, so that the
possibility that their transfer is altered by the hyperglycemic
state or the lack of insulin has not yet been studied. Changes
in the activities of the different iodothyronine-deiodinating
isoenzymes may also contribute to the observed concentra-
tions, but were not defined in the present experiment.
Effects on fetal development and thyroid hormone status
The reproductive competence of the present STZ-induced
diabetes mellitus pregnant rats was impaired, not only with
regard to the decreased number of fetuses per litter and the
increased frequency of resorptions, but also with respect to
2 Administration of insulin by infusionwithminipumpswas not used
for the present study, as despite repeated attempts with different insulin
preparations, the number of rats in which the pump did not clot was
limited, thus complicating the experimental approach considerably.
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the development of their fetuses, as assessed by BW. In our
study, the F-BWwas significantly reduced in fetuses from all
groups of STZ-injected dams, in agreement with the severity
of the diabetes and with reports by others using models
similar to the present one (12, 26) or with pregestational
diabetes (38) and data of babies born from poorly controlled
diabetic women (39–41). The growth impairment that exists
in the adult rat with diabetes mellitus is attributed at least in
part to decreased pituitary GH content and secretion (7)
resulting fromdecreasedGHmessenger RNA and decreased
GH transcription rate (42). Although the control of fetal
growth is not usually attributed to fetal GH, but to insulin-
like growth factors, the pituitary content of this hormonewas
lower in the fetuses from theDdams of the present study and
was closely correlated to their F-BW.
The changes in F-plasma glucose levels were clearly re-
lated to those in the maternal circulation, as previously
shown by others in rats (12) and sheep (43), as they have a
limited capacity to handle the glucose coming from their
hyperglycemic mothers. It is quite likely that the hypergly-
cemia of the D fetuses was responsible for exhaustion of an
overstimulated fetal pancreas (26), resulting in decreased
F-plasma insulin levels (11, 12). The thyroid hormone status
of the fetus was clearly affected by the maternal diabetes
mellitus, with regard to both intrathyroidal T4 and T3 con-
tents and extrathyroidal pools; bothweremarkedly reduced.
Morphological parameters, such as the decreased area of
epithelial cells, were consistent with a dormant thyroid in
fetuses from D dams (our unpublished observations), as
described for adult rats. This is in conceptual agreementwith
the finding that insulin is essential for the transcription of
two thyroid-specific genes, namely the thyroglobulin and
thyroid peroxidase genes (44, 45).
In fetuses from D dams, the concentrations of T4 and T3
were reduced in the circulation and all tissues studied, in-
cluding the carcass, with the total extrathyroidal stores re-
duced to one third of C values. This might not only be due
to decreased secretion by the fetal thyroid, but also to the
decrease in maternal T4 and T3 pools available for transport
(46) into the fetal compartment. A decreased availability of
maternal hormones could be aggravated by effects of the
maternal diabetes mellitus on M-placental function.
Whatever the relative roles played by the different mech-
anisms, the hyperglycemic fetuses presented all of the
changes found in theirmothers, including an increased%FT4
and decreased liver and lung 59D-I activities. 59D-II activity
in the fetal brain did not show the increase expected from the
low F-plasma and F-brain T4 (13–16), as a result of which
cerebral T3 concentrations were lower than those in normal
fetuses.
In contrast, the effects of insulin treatment of the dams on
fetal weight, circulating insulin levels, and thyroid hormone
economy did not parallel those observed in their mothers.
The different doses of insulin resulted in a normal increase
in the M-BW in all three groups of insulin-treated D dams
and dose-related increases in circulating insulin. The con-
centrations of T4 and T3 in M-plasma and most tissues also
appeared to increase with increasing insulin doses. In con-
trast, a clear improvement in F-BWwas only observed in the
D10.5 Ins group, the only group in which the number of
fetuses per litter was normal and resorptions absent and in
which F-plasma insulin levels were restored to normal val-
ues. Despite this improvement, a normal F-BW was not at-
tained, in agreementwith previous reports (11, 12). A normal
fetal pituitary GH content was not attained with any of the
insulin doses used in the present study. Although the fetal
pituitary GH content was not measured, Erikson et al. (38)
did not find normal F-BW when rat dams, injected with STZ
weeks before the onset of pregnancy, were treated with in-
sulin. We cannot at present explain these results and cannot
exclude a direct effect of STZ, injected on day 7 of gestation
into themothers, on the fetal pituitary. This appears unlikely,
considering that the decrease in pituitary GH in adult STZ-
treated rats is corrected with insulin (7). Maternal hyperin-
sulinemia (47) and intermittent hypoglycemia (48) also affect
fetal growth, and it is likely that such events accounted for
the poor results obtained by uswith the higher insulin doses,
considering that Ultralente insulin was used in the present
study.3 F-BW in these groups was closely related to their
pituitary GH content, not to F-plasma glucose or insulin
levels. F-plasma insulin levels decreased with the increasing
dose of insulin injected into their mothers and were as low
as those in fetuses from D dams in the hypoglycemic fetuses
of the D11.5 Ins dams, possibly because of continuous over-
stimulation leading to exhaustion of their b-cells.
Most parameters of thyroid status improved or actually
reverted to normal values in the fetuses from the D10.5 Ins
dams, including attainment of normal T3 concentrations in
the F-brain. The changes in T4 and T3 in the F-thyroid, F-
plasma, and F-tissues did not appear to be dose dependent
with respect to the insulin administered to their mothers,
being often more closely related to the F-BW and pituitary
GH content. If the latter parameters are taken as indexes of
fetal metabolic abnormalities and intracellular energy avail-
ability, it would appear that if adequate control of the ma-
ternal diabetic condition were achieved, the alterations in
fetal thyroid hormone economy, including brain T3 levels,
would be avoided.
Possible clinical relevance of the present findings
Fetal damage, abnormalities, and resorptions are well
known hazards of diabetes in pregnancy, whether in human
or experimental models (38, 49), especially when inade-
quately controlled, as evidenced by increasedmaternal b-hy-
droxybutyrate and triglyceride levels. Rizzo et al. (50) re-
ported that diabetes mellitus during pregnancy affects the
intellectual development and behavior of the progeny. They
found a correlation between the alterations in lipid metab-
olism of pregnant woman and the intelligence quotient of
their 2- to 3-yr-old children; the higher the levels of b-hy-
droxybutyrate and FFA, the lower the intelligence quotient
of the offspring. Considering that if the present results are
pertinent to man, brain T3 might have been low during a
3 We have no explanation regarding the very poor results obtained in
the D11.0 Ins fetuses, except that their mothers might have undergone
a wider range of daily fluctuations between a hyperglycemic and a
hypoglycemic state than the D11.5 Ins dams, which might have been
hypoglycemic throughout. Such fluctuations appear to be especially
harmful for the placenta (47).
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phase of development when thyroid hormones are of great
importance for brain development, it is possible that alter-
ations in fetal thyroid hormone status are contributing to this
intellectual impairment. Unfortunately, although the present
results would indicate that adequate control of the diabetes
mellitus appears to be of prime importance to prevent the
decrease in cerebral T3, such control is not easily achieved.
Relevance of present findings for nonthyroidal illness other
than diabetes mellitus
The diabetic dam displayed all of the changes in thyroid
hormone status considered typical of nonthyroidal illness,
changes that could be modulated and/or totally corrected
with insulin. We cannot at present exclude that some of the
effects observed in both the dams and the conceptus were
specifically related to the shortage of insulin and would not
be found in other models of nonthyroidal illness. However,
the changes in the concentrations of T4 in the circulation and
tissues of nonpregnant STZ-induced diabetes mellitus and
food-restricted rats have been shown to be related to energy
availability, as measured by the changes in BW, and not
specifically to the insulin levels (8). The same was found for
the concentration of T3 in brain, cerebellum, liver, and pi-
tuitary, whereas the T3 level in brown adipose tissue, heart,
muscle, and kidney were more specifically related to the
availability of insulin. Although the present experimental
design was not adequate to distinguish between the effects
of energy shortage and the lack of insulin, the findings we
report here may be relevant for other nonthyroidal illnesses
in which intracellular energy availability is impaired.
Conclusions
The present results show that maternal diabetes mellitus
and possibly maternal nonthyroidal illnesses compromising
intracellular energy availability result in severe impairment
of the thyroid hormone status of the fetus. This includes low
cerebral concentrations of T3 during a critical period of brain
development. Correction of the illness is necessary to protect
the brain, as compensatory mechanisms usually involved in
maintaining cerebral T3 homeostasis do not appear to be
operative.
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